Everolimus is associated with a reduced incidence of cytomegalovirus infection following de novo cardiac transplantation. (Q43523397)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Everolimus is associated with a reduced incidence of cytomegalovirus infection following de novo cardiac transplantation. |
scientific article |
Statements
Everolimus is associated with a reduced incidence of cytomegalovirus infection following de novo cardiac transplantation (English)
H Ross
C Bara
T Dengler
H B Lehmkuhl
S Witte
G Junge
26 September 2012
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference